Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys:: effects on basal ganglia GABAA/benzodiazepine receptor complex and GABA content

被引:42
作者
Calon, F
Morissette, M
Goulet, M
Grondin, R
Blanchet, PJ
Bédard, PJ
Di Paolo, T
机构
[1] Ctr Hosp Univ Quebec, Ctr Rech Endocrinol Mol, Quebec City, PQ G1V 4G2, Canada
[2] Univ Laval, Fac Pharm, Quebec City, PQ G1K 7P4, Canada
[3] Ctr Hosp Univ Quebec, Unite Rech Neurosci, Quebec City, PQ G1V 4G2, Canada
[4] Univ Laval, Fac Med, Dept Med, Quebec City, PQ G1K 7P4, Canada
基金
英国医学研究理事会;
关键词
Parkinson's disease; globus pallidus; dyskinesia; dopamine agonist; GABA; MPTP; flunitrazepam;
D O I
10.1016/S0197-0186(99)00064-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effect of various chronic dopaminergic treatments in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) monkeys on the brain gamma-aminobutyric acid type A (GABA(A)) /benzodiazepine receptor complex and GABA content was investigated in order to assess the GABAergic involvement in dopaminomimetic-induced dyskinesia. Three MPTP monkeys received for one month pulsatile administrations of the DI dopamine (DA) receptor agonist SKF 82958 whereas three others received the same dose of SKF 82958 by continuous infusion. A long acting D2 DA receptor agonist, cabergoline, was given to another three animals. Untreated MPTP as well as naive control animals were also included. Pulsatile SKF 82958 relieved parkinsonian symptoms but was also associated with dyskinesia in two of the three animals whereas animals treated continuously with SKF 82958 remained as untreated MPTP monkeys. Chronic cabergoline administration improved motor response with no persistent dyskinesia. MPTP treatment induced a decrease of H-3-flunitrazepam binding in the medial anterior part of caudate-putamen and an increase in the internal segment of globus pallidus (GPi) which was in general unchanged by pulsatile or continuous SKF 82958 administration. Throughout the striatum, binding of 3H-flunitrazepam remained reduced in MPTP monkeys treated with cabergoline but was not significantly lower than untreated MPTP monkeys. Moreover, cabergoline treatment reversed the MPTP-induced increase in H-3-flunitrazepam binding in the GPI. GABA concentrations remained unchanged in the striatum, external segment of globus pallidus and GPi following MPTP denervation. Pulsatile but not continuous SKF 82958 administration decreased putamen GABA content whereas cabergoline treatment decreased caudate GABA. No alteration in GABA levels were observed in the GPe and GPi following the experimental treatments. These results suggest that: (1) D2-like receptor stimulation with cabergoline modulates GABA(A) receptor density in striatal subregions anatomically related to associative cortical afferent and (2) the absence of dyskinesia in dopaminomimetic-treated monkeys might be associated with the reversal of the MPTP-induced upregulation of the GABA(A)/benzodiazepine receptor complex in the Gpi. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:81 / 91
页数:11
相关论文
共 53 条
[1]   BIOCHEMISTRY OF PARKINSONS-DISEASE 28 YEARS LATER - A CRITICAL-REVIEW [J].
AGID, Y ;
CERVERA, P ;
HIRSCH, E ;
JAVOYAGID, F ;
LEHERICY, S ;
RAISMAN, R ;
RUBERG, M .
MOVEMENT DISORDERS, 1989, 4 :S126-S144
[2]   THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J].
ALBIN, RL ;
YOUNG, AB ;
PENNEY, JB .
TRENDS IN NEUROSCIENCES, 1989, 12 (10) :366-375
[3]   HOMOLOGOUS DESENSITIZATION OF THE D1 DOPAMINE RECEPTOR [J].
BALMFORTH, AJ ;
WARBURTON, P ;
BALL, SG .
JOURNAL OF NEUROCHEMISTRY, 1990, 55 (06) :2111-2116
[4]   Double-crested Cormorant culling in the St Lawrence River Estuary [J].
Bedard, J ;
Nadeau, A ;
Lepage, M .
COLONIAL WATERBIRDS, 1995, 18 :78-85
[5]  
BEDARD PJ, 1993, ADV NEUROL, V60, P113
[6]  
BEDARD PJ, 1997, DECADE BRAIN, V2, P101
[7]   Dyskinesia and wearing-off following dopamine D-1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates [J].
Blanchet, PJ ;
Grondin, R ;
Bedard, PJ .
MOVEMENT DISORDERS, 1996, 11 (01) :91-94
[8]  
BLANCHET PJ, 1995, J PHARMACOL EXP THER, V272, P854
[9]   Dopamine D-1 receptor desensitization profile in MPTP-lesioned primates [J].
Blanchet, PJ ;
Grondin, R ;
Bedard, PJ ;
Shiosaki, K ;
Britton, DR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 309 (01) :13-20
[10]  
Blanchet PJ, 1995, J NEURAL TRANSM-SUPP, P103